Recombinant
RabMAb

Anti-RSK1 p90 (phospho T359 + S363) antibody [E238] (ab32413)

Publishing research using ab32413? Please let us know so that we can cite the reference in this datasheet.

ab32413 has been referenced in 5 publications.

  • Raguz J  et al. Epidermal RAF prevents allergic skin disease. Elife 5:N/A (2016). WB, IHC-P ; Mouse . PubMed: 27431613
  • Sueda T  et al. BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells. Sci Rep 6:18949 (2016). PubMed: 26750638
  • Henry JR  et al. Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cells. J Med Chem 58:4165-79 (2015). PubMed: 25965804
  • Chen X  et al. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. Oncogene N/A:N/A (2013). PubMed: 24141786
  • Chia KM  et al. A Feedback Loop between Androgen Receptor and ERK Signaling in Estrogen Receptor-Negative Breast Cancer. Neoplasia 13:154-66 (2011). IHC-P . PubMed: 21403841

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up